Ameliogenix Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

  • Investors
  • 1

Ameliogenix General Information

Description

Developer of immunotherapies and gene therapies designed to treat complex medical disorders. The company's technology utilizes amelogenin-derived peptides and biomineralization processes and provides Lipid Metabolism Research, Cardiovascular Innovation, Clinical Development, and Patient Impact, enabling healthcare providers and dental professionals to utilize regenerative protein-based enhancements to improve patient outcomes and ensure the remineralization of dental enamel.

Contact Information

Website
www.ameliogenix.ca
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 90 Landry Street
  • Ottawa, Ontario K1L 0A9
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 90 Landry Street
  • Ottawa, Ontario K1L 0A9
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ameliogenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Jan-2026 In Progress Generating Revenue
1. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
To view Ameliogenix’s complete valuation and funding history, request access »

Ameliogenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ameliogenix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Startup Garage Accelerator/Incubator
To view Ameliogenix’s complete investors history, request access »

Ready to get started?

Request a free trial

Ameliogenix FAQs

  • When was Ameliogenix founded?

    Ameliogenix was founded in 2023.

  • Where is Ameliogenix headquartered?

    Ameliogenix is headquartered in Ottawa, Canada.

  • What is the size of Ameliogenix?

    Ameliogenix has 2 total employees.

  • What industry is Ameliogenix in?

    Ameliogenix’s primary industry is Drug Discovery.

  • Is Ameliogenix a private or public company?

    Ameliogenix is a Private company.

  • What is Ameliogenix’s current revenue?

    The current revenue for Ameliogenix is .

  • Who are Ameliogenix’s investors?

    Startup Garage has invested in Ameliogenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process